The seemingly rebound global financial crisis has seriously eroded world economy from 2008,of which China's tumbling auto imports and exports business is a good example.At the beginning of 2008 it kicked off as an...The seemingly rebound global financial crisis has seriously eroded world economy from 2008,of which China's tumbling auto imports and exports business is a good example.At the beginning of 2008 it kicked off as an excellent year for the Chinese automotive market,but ended with the onset of a recession in last quarter both from the perspective of import and export.展开更多
Do you know which city in China's Mainland has ever crack the World's Top 100 Most Livable Cities list ranked by famous Mercer Human Resource Consulting? Yes,the answer is only Shanghai so far. In China,Shangh...Do you know which city in China's Mainland has ever crack the World's Top 100 Most Livable Cities list ranked by famous Mercer Human Resource Consulting? Yes,the answer is only Shanghai so far. In China,Shanghai possesses the similar position as Paris in France,and New York展开更多
The present paper examines China＇s biotechnology industry from a global perspective and explores how its development trajectory differs from that of countries that are leaders in biotechnology. We draw on diverse dat...The present paper examines China＇s biotechnology industry from a global perspective and explores how its development trajectory differs from that of countries that are leaders in biotechnology. We draw on diverse data to demonstrate the unique development trajectory of the industry in China. China has benefited through targeted spin-offs of R＆D-oriented foreign direct investment from developed countries driven by the effects of globalization, government-encouraged collaboration between the domestic academia and industry, and the input of overseas returnees. Together with an increasing focus of the government and domestic enterprises on independent innovation, such developments have enabled China to catch up with the global biotechnology industry. However, its small scale and low capacity for commercializing innovations under China ＂s current regulations and other barriers pose challenges for the development of the industry. Suggestions for the sustainable development of China＇s biotechnology industry are presented in this study.展开更多
文摘The seemingly rebound global financial crisis has seriously eroded world economy from 2008,of which China's tumbling auto imports and exports business is a good example.At the beginning of 2008 it kicked off as an excellent year for the Chinese automotive market,but ended with the onset of a recession in last quarter both from the perspective of import and export.
文摘Do you know which city in China's Mainland has ever crack the World's Top 100 Most Livable Cities list ranked by famous Mercer Human Resource Consulting? Yes,the answer is only Shanghai so far. In China,Shanghai possesses the similar position as Paris in France,and New York
基金the financial support from the National Science Foundation of China(No.71003061)the Alexander von Humboldt Foundation(2007-2008)+1 种基金the Special Support Fund for China's Postdoctor Research Fellow(201003090)the Humanities and the Social Sciences Project of the Ministry of Education(09YJC630225)
文摘The present paper examines China＇s biotechnology industry from a global perspective and explores how its development trajectory differs from that of countries that are leaders in biotechnology. We draw on diverse data to demonstrate the unique development trajectory of the industry in China. China has benefited through targeted spin-offs of R＆D-oriented foreign direct investment from developed countries driven by the effects of globalization, government-encouraged collaboration between the domestic academia and industry, and the input of overseas returnees. Together with an increasing focus of the government and domestic enterprises on independent innovation, such developments have enabled China to catch up with the global biotechnology industry. However, its small scale and low capacity for commercializing innovations under China ＂s current regulations and other barriers pose challenges for the development of the industry. Suggestions for the sustainable development of China＇s biotechnology industry are presented in this study.
